e-learning
resources
Courses
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of relapses
S. Tonstad (Oslo, Norway)
Source:
ERS Course 2015
Number:
31
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Tonstad (Oslo, Norway). Treatment of relapses. ERS Course 2015
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Results of Turkish smoking cessation polyclinics data’s analysis (TUSPA study)
Do e-cigarettes induce smoking cessation?
e-cigarettes for smoking cessation
Related content which might interest you:
Sarcoidosis relapses in corticosteroid treated patients
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis
Source: Eur Respir J 2014; 43: 602-609
Year: 2013
Early recurrent exacerbation and exacerbation therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 841s
Year: 2006
Retreatment of tuberculosis patients after the treatment interruption
Source: Eur Respir J 2006; 28: Suppl. 50, 506s
Year: 2006
Relapse after discontinuation of infliximab in sarcoidosis patients can be predicted by PET-scan and sIL-2R
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
Efficacy of α-tocoferol in the treatment of patients with pneumonia
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Evaluation of methotrexate in the treatment of severe asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Incidence and timing of hepatotoxicity due to anti-tuberculous treatment
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Treatment of sarcoidosis – pentoxifylline
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Long-term treatment with infliximab in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Surgical Treatment
Source: Research Seminar 2007 - The limits to exercise in COPD: new insights from new methods
Year: 2007
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Management of recurrent PE in patients on anticoagulant therapy
Source: Virtual Congress 2021 – Pulmonary embolism: special situations
Year: 2021
Treatment strategies
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept